{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:11:04Z","timestamp":1789765864906,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10554-019-01551-7","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T09:03:52Z","timestamp":1550739832000},"page":"1309-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"35","author":[{"given":"Syed R.","family":"Latif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-4294","authenticated-orcid":false,"given":"Vinh Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana C.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Soufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana L.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Grunseich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mojibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius","family":"Dicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Sinusas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papoutsidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-3449","authenticated-orcid":false,"given":"Lauren A.","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"1551_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2011.04.023","volume":"4","author":"G Quarta","year":"2011","unstructured":"Quarta G, Grasso A, Pasquale F et al (2011) Evaluation and clinical importance of fibrosis in HCM. J Am Coll Cardiol Imaging 4:1221\u20131223","journal-title":"J Am Coll Cardiol Imaging"},{"key":"1551_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.amjcard.2008.08.024","volume":"102","author":"BJ Maron","year":"2008","unstructured":"Maron BJ, Bonow RO, Salberg L et al (2008) The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol 102:1418\u20131420","journal-title":"Am J Cardiol"},{"key":"1551_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jcmg.2008.02.008","volume":"1","author":"IS Syed","year":"2008","unstructured":"Syed IS, Ommen SR, Breen JF et al (2008) Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging. J Am Coll Cardiol Imaging 1:377\u2013379","journal-title":"J Am Coll Cardiol Imaging"},{"key":"1551_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jcmg.2012.09.018","volume":"6","author":"G Moravsky","year":"2013","unstructured":"Moravsky G, Ofek E, Rakowski H et al (2013) Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. J Am Coll Cardiol Imaging 6:597\u2013599","journal-title":"J Am Coll Cardiol Imaging"},{"key":"1551_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jacc.2008.05.014","volume":"52","author":"N Reichek","year":"2008","unstructured":"Reichek N, Gupta D (2008) Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm. J Am Coll Cardiol 52:567\u2013568","journal-title":"J Am Coll Cardiol"},{"key":"1551_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","volume":"9","author":"Z Weng","year":"2016","unstructured":"Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. J Am Coll Cardiol Imaging 9:1392\u20131402","journal-title":"J Am Coll Cardiol Imaging"},{"key":"1551_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","volume":"56","author":"O Bruder","year":"2010","unstructured":"Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875\u2013887","journal-title":"J Am Coll Cardiol"},{"key":"1551_CR8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/eurheartj\/ehv529","volume":"37","author":"OA Smiseth","year":"2016","unstructured":"Smiseth OA, Torp H, Opdahl A et al (2016) Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 37:1196\u20131207","journal-title":"Eur Heart J"},{"key":"1551_CR9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.echo.2008.09.011","volume":"21","author":"ZB Popovic","year":"2008","unstructured":"Popovic ZB, Kwon DH, Mishra M et al (2008) Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyper-enhancement magnetic resonance imaging. J Am Soc Echocardiogr 21:1299\u20131305","journal-title":"J Am Soc Echocardiogr"},{"key":"1551_CR10","first-page":"617","volume":"13","author":"M Saito","year":"2012","unstructured":"Saito M, Okayama H, Yoshii T et al (2012) Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J 13:617\u2013623","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"1551_CR11","doi-asserted-by":"publisher","first-page":"E122","DOI":"10.1186\/1532-429X-15-S1-E122","volume":"15","author":"L Macron","year":"2013","unstructured":"Macron L, Redheuil A, Ashrafpoor G et al (2013) Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement. J Cardiovasc Magn Reson 15(Suppl 1):E122","journal-title":"J Cardiovasc Magn Reson"},{"key":"1551_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.echo.2008.11.001","volume":"22","author":"MA Losi","year":"2009","unstructured":"Losi MA, Betocchi S, Barbati G et al (2009) Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 22:76\u201381","journal-title":"J Am Soc Echocardiogr"},{"key":"1551_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","volume":"18","author":"H Yang","year":"2005","unstructured":"Yang H, Woo A, Monakier D et al (2005) Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 18:1074\u20131082","journal-title":"J Am Soc Echocardiogr"},{"issue":"21","key":"1551_CR14","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto I, Cecchi F, Casey SA et al. (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104(21):2517\u20132524","journal-title":"Circulation"},{"key":"1551_CR15","doi-asserted-by":"publisher","first-page":"iii22","DOI":"10.1093\/europace\/eun223","volume":"10","author":"TH Hauser","year":"2008","unstructured":"Hauser TH, Peters DC, Wylie JV et al (2008) Evaluating the left atrium by magnetic resonance imaging. Europace 10:iii22\u2013iii27","journal-title":"Europace"},{"key":"1551_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28:1\u201339","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"1551_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12968-018-0448-9","volume":"20","author":"JJ Cao","year":"2018","unstructured":"Cao JJ, Ngai N, Duncanson L et al (2018) A comparison of both DENSE and feature tracking techniques with tagging for the cardiovascular magnetic resonance assessment of myocardial strain. J Cardiovasc Magn Reson 20(1):26","journal-title":"J Cardiovasc Magn Reson"},{"key":"1551_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12968-016-0269-7","volume":"18","author":"G Pedrizzetti","year":"2016","unstructured":"Pedrizzetti G, Claus P, Kilner PJ et al (2016) Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson 18:51","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"1551_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1532-429X-15-105","volume":"15","author":"R Karim","year":"2013","unstructured":"Karim R, Housden R, Balasubramaniam M et al (2013) Evaluation of current algorithms for segmentation of scar tissue from late Gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge. J Cardiovasc Magn Reson 15(1):105","journal-title":"J Cardiovasc Magn Reson"},{"key":"1551_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijcard.2009.10.032","volume":"148","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Funabashi N, Uehara M et al (2011) Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transition from paroxysmal to chronic form. Int J Cardiol 148:139\u2013147","journal-title":"Int J Cardiol"},{"key":"1551_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4614-7657-3_19","volume-title":"Intraoperative imaging and image-guided therapy","author":"R Kikinis","year":"2014","unstructured":"Kikinis R, Pieper SD, Vosburgh KG (2014) 3D Slicer: a platform for subject-specific image analysis, visualization, and clinical support. In Intraoperative imaging and image-guided therapy (pp.\u00a0277\u2013289). Springer, New York"},{"key":"1551_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12968-018-0514-3","volume":"21","author":"M Quail","year":"2019","unstructured":"Quail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC (2019) Prognostic and functional implications of left atrial late gadolinium enhancement. J Cardiovasc Magn Reson 21:2","journal-title":"J Cardiovasc Magn Reson"},{"key":"1551_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jce.12651","volume":"26","author":"H Cochet","year":"2015","unstructured":"Cochet H, Mouries A, Nivet H et al (2015) Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol 26:484\u2013492","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"1551_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jama.2014.3","volume":"311","author":"NF Marrouche","year":"2014","unstructured":"Marrouche NF, Wilber D, Hindricks G et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311(5):498\u2013506","journal-title":"JAMA"},{"issue":"5","key":"1551_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.hrthm.2008.02.008","volume":"5","author":"JV Wylie","year":"2008","unstructured":"Wylie JV, Peters DC, Essebag V et al (2008) Left atrial function and scar after catheter ablation of atrial fibrillation. Heart Rhythm 5(5):656\u2013662","journal-title":"Heart Rhythm"},{"key":"1551_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RC Chan","year":"2014","unstructured":"Chan RC, Maron BJ, Olivotto I et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484\u2013495","journal-title":"Circulation"},{"issue":"3","key":"1551_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/RLI.0000000000000326","volume":"52","author":"JT Kowallick","year":"2017","unstructured":"Kowallick JT, Vieira MS, Kutty S et al (2017) Left atrial performance in the course of hypertrophic cardiomyopathy: relation to left ventricular hypertrophy and fibrosis. Invest Radiol 52(3):177\u2013185","journal-title":"Invest Radiol"},{"key":"1551_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCEP.116.004052","volume":"10","author":"P Debonnaire","year":"2017","unstructured":"Debonnaire P, Joyce E, Hiemestra Y et al (2017) LA size and function versus AF risk in HCM. Circ Arrhythm Electrophys 10:1\u201310","journal-title":"Circ Arrhythm Electrophys"},{"issue":"1","key":"1551_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12968-017-0420-0","volume":"19","author":"H Farhad","year":"2017","unstructured":"Farhad H et al (2017) Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. J Cardiovasc Magn Reson 19(1):107","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"1551_CR30","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","volume":"165","author":"HD Xiao","year":"2004","unstructured":"Xiao HD et al (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165(3):1019\u20131032","journal-title":"Am J Pathol"},{"key":"1551_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/01.RES.86.5.571","volume":"86","author":"H Nakajima","year":"2000","unstructured":"Nakajima H, Nakajima HO, Salcher O et al (2000) Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta (1) transgene in the heart. Circ Res 86:571\u2013579","journal-title":"Circ Res"},{"key":"1551_CR32","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","volume":"94","author":"S Verheule","year":"2004","unstructured":"Verheule S, Sato T, Everett T et al (2004) Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 94:1458\u20131465","journal-title":"Circ Res"},{"key":"1551_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.RES.69.1.116","volume":"69","author":"W Carver","year":"1991","unstructured":"Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L (1991) Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 69:116\u2013122","journal-title":"Circ Res"},{"key":"1551_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jcmg.2016.01.015","volume":"10","author":"DC Peters","year":"2017","unstructured":"Peters DC, Duncan JS, Grunseich K et al (2017) CMR-verified lower LA strain in the presence of regional atrial fibrosis in atrial fibrillation. J Am Coll Cardiol Imaging 10:207\u2013208","journal-title":"J Am Coll Cardiol Imaging"},{"issue":"12","key":"1551_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1161\/01.CIR.0000090687.97972.10","volume":"108","author":"R Lombardi","year":"2003","unstructured":"Lombardi R, Betocchi S, Losi MA et al (2003) Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108(12):1455\u20131460","journal-title":"Circulation"},{"issue":"6","key":"1551_CR36","first-page":"613","volume":"17","author":"TF Haland","year":"2016","unstructured":"Haland TF et al (2016) Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J 17(6):613\u2013621","journal-title":"Eur Heart J"},{"issue":"3","key":"1551_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/europace\/eur002","volume":"13","author":"I Savelieva","year":"2011","unstructured":"Savelieva I, Kakouros N, Kourliouros A et al (2011) Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace 13(3):308\u2013328","journal-title":"Europace"},{"issue":"5","key":"1551_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","volume":"45","author":"K Wachtell","year":"2005","unstructured":"Wachtell K, Lehto M, Gerdts E et al (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45(5):712\u2013719","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1551_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","volume":"149","author":"AP Maggioni","year":"2005","unstructured":"Maggioni AP, Latini R, Carson PE et al (2005) Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the valsartan heart failure trial (Val-HeFT). Am Heart J 149(3):548\u2013557","journal-title":"Am Heart J"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-019-01551-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:08:55Z","timestamp":1582225735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-019-01551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1551"],"URL":"https:\/\/doi.org\/10.1007\/s10554-019-01551-7","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Yale IRBS\u2014Yale University Institutional Review Board, specifically the Human Investigation Committee, and is HIPAA compliant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No informed consent was required since this is a retrospective data review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}